Abstract 2877: MRG007, a cadherin 17-targeted, glycan-linked, exatecan-based antibody-drug conjugate, demonstrated potent anti-tumor activity and a good safety profile in preclinical studies
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Peng Zeng, Qi Wu, Yongjun An, Yili Feng, Yanchun Wang, Shoujia Liu, Deliang Li, Feifei Cui, Lei Fang
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409689936
